Practical use of non-steroidal anti-inflammatory drugs in relieving recurrent headaches

Cover Page

Cite item

Full Text

Abstract

The main burden of headache in the world falls on primary cephalalgia (tension headache, migraine). However, there is often a need to rule out a secondary cause of the headache. This review presents the main options for the differential diagnosis of cephalgias, taking into account the patient's age, headache characteristics, and anamnestic information. The role of non-steroidal anti-inflammatory drugs in headache treatment, the safety of its long-term use and prevention of medication overuse headache are discussed.

About the authors

Gyuzyal R. Tabeeva

Sechenov First Moscow State Medical University (Sechenov University)

Email: grtabeeva@gmail.com
д-р мед. наук, проф. каф. Moscow, Russia

Ekaterina A. Kiryanova

Sechenov First Moscow State Medical University (Sechenov University)

аспирант каф. Moscow, Russia

References

  1. Stovner L, Hagen K, Jensen R. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27 (3): 193-210. doi: 10.1111/j.1468-2982.2007.01288.x
  2. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163-96. doi: 10.1016/S0140-6736(12)61729-2
  3. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1603-58. doi: 10.1016/S0140-6736(16)31460-X
  4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018; 38 (2): 182-90. doi: 10.1055/s-00000071
  5. Ayzenberg I, Katsarava Z, Sborowski A. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol. 2014; 21 (05): 758-65. doi: 10.1111/ene.12380
  6. Mukendi D, Lilo Kalo JR, Mpanya A. Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo. Am J Trop Med Hyg. 2017; 97 (05): 1454-60. doi: 10.4269/ajtmh.17-0375
  7. Gatti F, Manneschi L. Headache relevance in outpatient activity during Covid-19 pandemic. Neurol Sci. 2020; 41 (2): 481-2. doi: 10.1007/s10072-020-04666-1
  8. Ong JJY, Bharatendu C, Goh Y, et al. Headaches Associated with Personal Protective Equipment - a cross-sectional study amongst frontline healthcare workers during COVID-19 (HAPPE Study). Headache. 2020; 60: 864-77. doi: 10.1111/head.13811
  9. Caronna E, Ballve A, Llaurado A et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40 (13): 1410-21. doi: 10.1177/0333102420965157
  10. Pohl H, Do TP, Garcia-Azorin D, et al. Green Flags and headache: A concept study using the Delphi method. Headache. 2021; 61 (2): 300-9. doi: 10.1111/head.14054
  11. Наприенко М.В., Филатова Е.Г., Смекалкина Л.В., Макаров С.А. Головная боль напряжения. Повторение пройденного. Consilium Medicum. 2019; 21 (2): 79-85
  12. Осипова В.В., Филатова Е.Г., Артеменко А.Р, и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Журн. неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (1-2): 28-42
  13. Longoni M, Agostoni EC. Headache in neurological emergency. NeurolSci. 2020; 41 (2): 409-16. doi: 10.1007/s10072-020-04761-3
  14. Headache Classification Committee of the International Headache Society. HIS The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018; 38 (1): 1-211. doi: 10.1177/0333102417738202
  15. Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005; 45: 597. doi: 10.1111/j.1526-4610.2005.05114.x
  16. Leira EC, Cruz-Flores S, Leacock RO. Sumatriptan can alleviate headaches due to carotid artery dissection. Headache. 2001; 41: 590. doi: 10.1046/j.1526-4610.2001.041006590.x
  17. Prokhorov S, Khanna S, Alapati D Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. Headache. 2008; 48: 1235. doi: 10.1111/j.1526-4610.2008.01151.x
  18. Lipton RB, Mazer C, Newman LC. Sumatriptan relieves migraine-like headaches associated with carbon monoxide exposure. Headache. 1997; 37: 392. doi: 10.1046/j.1526-4610.1997.3706392.x
  19. Luciani M, Negro A, Spunatrelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021; 21 (3): 277-85. doi: 10.1080/14737175.2021.1863148
  20. Forderreuther S. Kopfschmerzen als Notfall sind leicht ubersehen. Schmerz. 2020; 34: 517-24. doi: 10.1007/s00482-020-00513-6
  21. Vidale S. Headache in cervicocerebral artery dissection. Neurol Sci. 2020; 41: 395-9. doi: 10.1007/s10072-020-04651-8
  22. Diamanti S, Longoni M, Agostoni EC. Leading symptoms in cerebrovascular diseases: what about headache? Neurol Sci. 2019; 40 (1): 147-52. doi: 10.1007/s10072-019-03793-8
  23. Tarulli A. Headache and Facial Pain. Neurology. 2020: 265-87. doi: 10.1007/978-3-030-55598-6_19
  24. Sekhon S, Sharma R, Cascella M. Thunderclap Headache. In: StatPearls. Treasure Island: StatPearls Publishing, 2020.
  25. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. Am J Neuroradiol. 2015; 36 (8): 1392-9. doi: 10.3174/ajnr.A4214
  26. Ju YE, Schwedt TJ. Abrupt-onset severe headaches. Semin Neurol. 2010; 30 (2): 192-200. doi: 10.1055/s-0030-1249229
  27. Devenney E, Neale H, Forbes RB. A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based? J Headache Pain. 2014; 15 (1): 49. doi: 10.1186/1129-2377-15-49
  28. Joshi SG, Cho TA. Pathophysiological mechanisms of headache in patients with HIV. Headache.2014; 54 (5): 946-50. doi: 10.1111/head.12356
  29. Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014; 82 (9): 806-13. doi: 10.1212/WNL.0000000000000172
  30. Schankin CJ, Ferrari U, Reinisch VM. Characteristics of brain tumour-associated headache. Cephalalgia. 2007; 27 (8): 904-11. doi: 10.1111/j.1468-2982.2007.01368.x
  31. Palmieri A, Valentinis L, Zanchin G. Update on headache and brain tumors. Cephalalgia. 2020: 0333102420974351. doi: 10.1177/0333102420974351
  32. Чечет Е.А., Табеева Г.Р Цервикогенная головная боль. Медицинский совет. 2015; 4: 76-81. Режим доступа: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Ссылка активна на 07.04.2021
  33. Aliprandi A, Borelli P, Polonia V, Salmaggi A. Headache in cerebral venous thrombosis. NeurolSci. 2020; 41 (2): 401-6. doi: 10.1007/s10072-020-04784-w
  34. Aladakatti R, Sannakki LB, Cai PY, Derequito R. Thunderclap headache: It is always sub-arachnoid hemorrhage. Is it? A case report and Review. Surg Neurol Int. 2014; 5: 22. doi: 10.4103/2152-7806.127756
  35. Negro A, Spuntarelli V, Sciattella P. Rapid referral for headache management from emergency department to headache centre: four years data. J Headache Pain. 2020; 21 (25): 1-11. doi: 10.1186/s10194-020-01094-6
  36. Valade D, Lucas C, Calvel L. Migraine diagnosis and management in general emergency departments in France. Cephalalgia. 2011; 31: 471-80. doi: 10.1177/0333102410378178
  37. Gupta MX, Silberstein SD, Young WB. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125-33. doi: 10.1111/j.1526-4610.2007.00846.x
  38. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSA-IDs the same? A narrative review. Adv Ther. 2020; 37 (1): 61-82. doi: 10.1007/s12325-019-01144-9
  39. Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014; 155 (1): 14-21. doi: 10.1016/j.pain.2013.08.013
  40. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database SystRev. 2011: CD008659. doi: 10.1002/14651858.CD008659.pub3
  41. Van Den Brink MA, de Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic. J Headache Pain. 2020; 21 (1): 38. doi: 10.1186/s10194-020-01106-5
  42. Peck J, Urits I, Zeien J, et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020; 24 (5): 19. doi: 10.1007/s11916-020-00852-0
  43. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database SystRev. 2010; 4. doi: 10.1002/14651858.CD008039.pub2

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies